MolecularHealth, FDA Sign Five-Year Pact to Improve Drug Safety Assessment Software
February 17, 2012
MolecularHealth, FDA Sign Five-Year Pact to Improve Drug Safety Assessment Software
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- SV Bio Seeks Foothold in NGS-Based Clinical Dx Market with Proprietary Interpretation Pipeline
January 18, 2013 / BioInform - New Players, Clinical Applications, and the Lure of Commercialization among 2012 Bioinformatics Trends
January 4, 2013 / BioInform - MolecularHealth Partners With SAP to Accelerate Decision-Support Software for Oncology Treatment
November 16, 2012 / BioInform - MolecularHealth, FDA to Evaluate Drug Safety Assessment Software
February 14, 2012 / GenomeWeb Daily News - Newly Renamed MolecularHealth Rolls Out Drug Safety-Assessment Software
January 20, 2012 / BioInform